• Return to Headlines

Shares of Advaxis Inc Fall to a New 52-Week Low

By James Quinn

Advaxis Inc (NASDAQ:ADXS) traded at a new 52-week low today of $1.75. Approximately 1.4 million shares have changed hands today, as compared to an average 30-day volume of 822,000 shares.

Advaxis Inc (NASDAQ:ADXS) has potential upside of 1,094.4% based on a current price of $1.80 and analysts' consensus price target of $21.50. The stock should run into initial resistance at its 50-day moving average (MA) of $8.51 and subsequent resistance at its 200-day MA of $10.90.

Over the past year, Advaxis Inchas traded in a range of $1.75 to $16.30 and are now at $1.80. The 200-day and 50-day moving averages have moved 2.02% lower and 1.42% higher over the past week, respectively.

Advaxis Inc., is a biotechnology company. The Company develops therapeutic cancer vaccines targeting cervical, head and neck, breast, prostate, and other cancers.

SmarTrend recommended that its subscribers protect gains by selling shares of Advaxis Inc on September 13th, 2017 by issuing a Downtrend alert when the shares were trading at $5.13. Since that call, shares of Advaxis Inc have fallen 56.9%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows advaxis inc

Ticker(s): ADXS